Who should receive extended infusion beta-lactam therapy?

JAAPA

Christopher Roman is an assistant professor in the PA program at Butler University in Indianapolis, Ind. Tia Solh is an academic coordinator and assistant professor in the PA program at Philadelphia College of Osteopathic Medicine in Suwanee, Ga. Kendra M. Damer is an associate professor of pharmacy practice in Butler University's College of Pharmacy and Health Sciences. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Published: March 2016

The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88DOI Listing

Publication Analysis

Top Keywords

extended infusion
8
receive extended
4
infusion beta-lactam
4
beta-lactam therapy?
4
therapy? increasing
4
increasing prevalence
4
prevalence antibiotic-resistant
4
antibiotic-resistant bacteria
4
bacteria challenges
4
challenges clinician's
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!